1st Circ. Upholds Sarepta Win In Drug Trial Investor Suit
The First Circuit on Wednesday sided with Sarepta Therapeutics Inc. in a lawsuit claiming the company hid concerns about the clinical trial and regulatory outlook of a treatment for a type...To view the full article, register now.
Already a subscriber? Click here to view full article